65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2100043049
2021-02-042021-02-04The application of T/B cell antigen-treated shear ring (Trecs/Krecs) quantitative PCR detection in neonatal screening for primary immunodeficiency diseaseThe application of T/B cell antigen-treated shear ring (Trecs/Krecs) quantitative PCR detection in neonatal screening for primary immunodeficiency disease Severe combined immunodeficiencyGold Standard:TRECs: 40 copies / µ l whole blood
Krecs: 40 copies / µ l whole blood
RNase P: 2000 copies / µ l whole blood;Index test:Quantitative detection of TRECs / krecs and housekeeping gene plasmid by PCR;
Chengdu Women's and Children's Center HospitalNULLRecruitingBothTarget condition:20000;Difficult condition:0China
2ChiCTR2000032139
2020-09-012020-04-20Newborn screening and precision medical system construction for primary immunodeficiency diseaseNewborn screening and precision medical system construction for primary immunodeficiency disease primary immunodeficiencyGold Standard:1. Whether there is immune deficiency;
2. Primary or secondary, persistent or temporary;
3. The part and degree of the defect of immune system;
4. Molecular diagnosis: sequence the first / second generation genes to detect whether there is pathogenic gene mutation; detection of relative protein molecular.;Index test:PID newborn screening technology system based on TRECs/KRECs combined with quantitative PCR detection;
Children's Hospital of Chongqing Medical UniversityNULLRecruiting01BothTarget condition:50000;Difficult condition:0China